News

A nanomesh device which reads the field potential of cardiomyocytes could aid the study of other cells, organs and medicines, and also paves the way for future embedded medical devices.

A process has been developed to chemically attach nanoparticles of anti-cancer drugs onto attenuated bacteria cells, which have been shown to be more effective than the passive delivery of injections at reaching cancer sites.

Researchers discover copper has potential as a catalyst for turning carbon dioxide into sustainable chemicals and fuels without any wasteful byproducts, creating a green alternative to present-day chemical manufacturing.

A vaccine has been developed that would defend against Zika virus without producing antibodies.

Biomedical engineers led an international team to determine which patients would benefit most from a commonly used drug.

This new technique paves the way for creation of protein nanomachines and engineering of new cell functions.

A Zika virus vaccine has protected mouse fetuses against brain infections and malformations, warranting further exploration as a vaccine candidate.

Patient-specific tumor ‘organoid’ models have been developed to identify the most effective treatment for each appendix tumor.

Researchers from the Swiss Tropical and Public Health Institute together with colleagues from Singapore have discovered a highly effective compound against Buruli ulcer which has the potential to become a powerful alternative to the existing treatment options.

Researchers have determined that HPV takes the help of a protein present in our cells (USP46) which becomes essential for HPV-induced tumor formation and growth. USP46 could be a promising therapeutic target.